• FirefoxInstall the new Firefox »
  •  Dow Down0.45% Nasdaq Down0.49%

    More On CADX

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    Ownership

    Financials

    • Income Statement
    • Balance Sheet
    • Cash Flow

    Cadence Pharmaceuticals Inc. (CADX)

    -NasdaqGS
    13.98 0.00(0.00%) Mar 18, 4:00PM EDT
    Add to Portfolio
    Analyst OpinionGet Analyst Opinion for:
    Recommendation Summary*
    Mean Recommendation (this week):1.0
    Mean Recommendation (last week):2.4
    Change:-1.4

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Price Target Summary
    Mean Target:11.00
    Median Target:11.00
    High Target:14.00
    Low Target:8.00
    No. of Brokers:2

    Data provided by Thomson/First Call

    Upgrades & Downgrades History
    DateResearch FirmActionFromTo
    Nov 17, 2011OppenheimerUpgradeUnderperformPerform
    Mar 7, 2011Ladenburg ThalmannUpgradeSellNeutral
    Dec 16, 2010UBSInitiated Neutral
    Nov 3, 2010Ladenburg ThalmannDowngradeNeutralSell
    Apr 16, 2010OppenheimerDowngradePerformUnderperform
    Nov 16, 2009OppenheimerDowngradeOutperformPerform
    Oct 9, 2009JMP SecuritiesUpgradeMkt PerformMkt Outperform
    Jul 21, 2009JMP SecuritiesUpgradeMkt UnderperformMkt Perform
    Jun 11, 2009JMP SecuritiesDowngradeMkt PerformMkt Underperform
    May 13, 2009JMP SecuritiesDowngradeMkt OutperformMkt Perform

    More Upgrades & Downgrades for CADX

    Data provided by Briefing.com - Take a free trial
    Complete Live market analysis of the U.S. stock and bond markets, technology stocks, economic releases, earnings reports, and day trading highlights.

    Recommendation Trends
    Current MonthLast MonthTwo Months AgoThree Months Ago
    Strong Buy0000
    Buy0000
    Hold0000
    Underperform0000
    Sell0000

    Data provided by Thomson/First Call


    Currency in USD.